Filtered By:
Source: Heart Rhythm
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 406 results found since Jan 2013.
Cryptogenic stroke: Is silent atrial fibrillation the culprit?
Stroke without an identifiable cause is frightening to patients and their families and is frustrating for the caring physician. Approximately 30% of patients with cardiac implanted electronic devices have some evidence of atrial fibrillation (AF), and much of it is silent, asymptomatic, and previously unrecognized.
Source: Heart Rhythm - October 3, 2014 Category: Cardiology Authors: Taya V. Glotzer, Paul D. Ziegler Source Type: research
The Metabolic Syndrome, Atrial Fibrillation and Stroke: Tackling An Emerging Epidemic
The prevalence of atrial fibrillation (AF) and AF-related stroke is set to increase dramatically in coming decades, with developing regions such as Latin America experiencing the greatest impact. These trends are primarily driven by aging populations and by the increasing prevalence of metabolic syndrome. Metabolic syndrome describes an association between diabetes, hypertension, obesity, dyslipidaemia and an increased risk of cardiovascular disease. It is in large part the result of unbalanced diet and sedentary lifestyle.
Source: Heart Rhythm - June 30, 2015 Category: Cardiology Authors: Reza Hajhosseiny, Gareth K. Matthews, Gregory YH Lip Tags: CRV Source Type: research
The metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
The prevalence of atrial fibrillation (AF) and AF-related stroke is set to increase dramatically in coming decades, with developing regions such as Latin America experiencing the greatest impact. These trends are primarily driven by aging populations and by the increasing prevalence of the metabolic syndrome. The metabolic syndrome describes an association between diabetes, hypertension, obesity, and dyslipidemia and an increased risk of cardiovascular disease. It is in large part the result of unbalanced diet and sedentary lifestyle.
Source: Heart Rhythm - June 30, 2015 Category: Cardiology Authors: Reza Hajhosseiny, Gareth K. Matthews, Gregory Y.H. Lip Tags: Contemporary Review Source Type: research
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
The prevalence of atrial fibrillation (AF) and AF-related stroke is set to increase dramatically in coming decades, with developing regions such as Latin America experiencing the greatest impact. These trends are primarily driven by aging populations and by the increasing prevalence of the metabolic syndrome. The metabolic syndrome describes an association between diabetes, hypertension, obesity, and dyslipidemia and an increased risk of cardiovascular disease. It is in large part the result of unbalanced diet and sedentary lifestyle.
Source: Heart Rhythm - June 30, 2015 Category: Cardiology Authors: Reza Hajhosseiny, Gareth K. Matthews, Gregory Y.H. Lip Tags: Contemporary Review Source Type: research
Comparisons of CHADS2 and CHA2DS2-VASc Scores for Stroke Risk Stratification in Atrial Fibrillation – Which Scoring System should be Used for Asians?
Both American and European guidelines recommended the use of CHA2DS2-VASc score, rather than CHADS2, for stroke risk stratification in atrial fibrillation (AF). However, the CHA2DS2-VASc score has not been proved to be better than CHADS2 for Asians in a large-scale study.
Source: Heart Rhythm - August 12, 2015 Category: Cardiology Authors: Tze-Fan Chao, Chia-Jen Liu, Ta-Chuan Tuan, Su-Jung Chen, Kang-Ling Wang, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Tzeng-Ji Chen, Chern-En Chiang, Shih-Ann Chen Source Type: research
Comparisons of CHADS and CHADS-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?
Both U.S. and European guidelines recommend use of the CHA2DS2-VASc rather than CHADS2 score for stroke risk stratification in atrial fibrillation (AF). However, the CHA2DS2-VASc score has not been proved to be better than CHADS2 score for Asians in a large-scale study.
Source: Heart Rhythm - August 12, 2015 Category: Cardiology Authors: Tze-Fan Chao, Chia-Jen Liu, Ta-Chuan Tuan, Su-Jung Chen, Kang-Ling Wang, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Tzeng-Ji Chen, Chern-En Chiang, Shih-Ann Chen Source Type: research
Over One Year Efficacy and Safety of Left Atrial Appendage Occlusion Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies
Direct comparison of the efficacy and safety profile between left atrial appendage occlusion (LAAO) devices and novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation (AF) is warranted but currently unavailable.
Source: Heart Rhythm - December 24, 2015 Category: Cardiology Authors: Xin Li, Song-Nan Wen, Song-Nan Li, Rong Bai, Nian Liu, Li Feng, Yan-Fei Ruan, Xin Du, Jian-Zeng Dong, Chang-Sheng Ma Source Type: research
Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies
A direct comparison of the efficacy and safety profiles of left atrial appendage occlusion (LAAO) devices and novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation is warranted but currently unavailable.
Source: Heart Rhythm - December 24, 2015 Category: Cardiology Authors: Xin Li, Song-Nan Wen, Song-Nan Li, Rong Bai, Nian Liu, Li Feng, Yan-Fei Ruan, Xin Du, Jian-Zeng Dong, Chang-Sheng Ma Source Type: research
Warfarin Use and the Risk of Mortality, Stroke, and Bleeding in Hemodialysis Patients with Atrial Fibrillation
The optimal management of stroke prophylaxis in hemodialysis patients with atrial fibrillation is controversial.
Source: Heart Rhythm - February 5, 2017 Category: Cardiology Authors: Brandon Kai, Yuliya Bogorad, Leigh-Ann N. Nguyen, Su-Jau Yang, Wansu Chen, Hillard T. Spencer, Albert Y.-J. Shen, Ming-Sum Lee Source Type: research
Benefits of non –vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke prevention
The last decade has produced a large body of robust randomized controlled trial (RCT) data investigating the use of non –vitamin K antagonist oral anticoagulants (NOACs) in nonvalvular atrial fibrillation (AF).1–4 Compared with warfarin, dabigatran and apixaban have been found to reduce the combined outcome of stroke and systemic embolism. In addition, apixaban and edoxaban significantly reduce major bleeding. Fu rthermore, a pooled meta-analysis has demonstrated superior efficacy and overall safety of the NOACs.
Source: Heart Rhythm - January 15, 2017 Category: Cardiology Authors: Jay A. Montgomery, Gregory F. Michaud Tags: Editorial Commentary Source Type: research
Irregularity and lack of p-waves in short tachycardia episodes predict atrial fibrillation and ischemic stroke
Atrial fibrillation (AF) is defined as an irregular supraventricular tachycardia (SVT) without p-waves, with a duration>30s. It is not known whether AF characteristics in shorter SVT episodes predict AF and stroke.
Source: Heart Rhythm - February 12, 2018 Category: Cardiology Authors: Linda S.B. Johnson, Anders P. Persson, Per Wollmer, Steen Juul-M öller, Tord Juhlin, Gunnar Engström Source Type: research
Irregularity and lack of p waves in short tachycardia episodes predict atrial fibrillation and ischemic stroke
Atrial fibrillation (AF) is defined as an irregular supraventricular tachycardia (SVT) without p waves, with duration>30 seconds. Whether AF characteristics during short SVT episodes predict AF and stroke is not known.
Source: Heart Rhythm - February 12, 2018 Category: Cardiology Authors: Linda S.B. Johnson, Anders P. Persson, Per Wollmer, Steen Juul-M öller, Tord Juhlin, Gunnar Engström Source Type: research
Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study
Several cardiovascular diseases exhibit seasonal variations, but data about cold temperature and risk of ischemic stroke in patients with atrial fibrillation (AF) are limited.
Source: Heart Rhythm - July 2, 2018 Category: Cardiology Authors: Jo-Nan Liao, Tze-Fan Chao, Chia-Jen Liu, Su-Jung Chen, Chung-Lieh Hung, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Fa-Po Chung, Tzeng-Ji Chen, Gregory Y.H. Lip, Shih-Ann Chen Source Type: research
Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removal
Stroke can be a devastating complication in patients with cardiovascular implantable electronic device (CIED) infection. Paradoxical septic embolism can occur in the presence of device leads and patent foramen ovale (PFO) via embolic dislodgment during transvenous lead removal (TLR).
Source: Heart Rhythm - October 30, 2018 Category: Cardiology Authors: Justin Z. Lee, Pradyumna Agasthi, Ahmed K. Pasha, Claudia Tarin, Andrew S. Tseng, Nancy N. Diehl, David O. Hodge, Christopher V. DeSimone, Ammar M. Killu, Peter A. Brady, Krishna Kancharla, Fred M. Kusumoto, Komandoor Srivathsan, Michael J. Osborn, Raul E Tags: Featured Article Source Type: research
